Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC for Osteoarthritis
NCT02237846Phase 2Withdrawn
- Sponsor
- Translational Biosciences
- Start
- Sep 2014
- Primary completion
- Nov 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord tissue-derived mesenchymal stem cells in knee osteoarthritis (OA), sponsored by Translational Biosciences. Planned start Sep 2014; status: withdrawn.
02
Drugs
human umbilical cord tissue-derived mesenchymal stem cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02237846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237846.